Will Heron Therapeutics (HRTX) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/28/21
Heron Therapeutics Announces Publication of Results from HOPE (Helping Opioid Prescription Elimination), Showing ZYNRELEF™ Minimizes the Need for Opioids in a Real-World Setting, With 95% of Patients Experiencing an Opioid-free RecoveryPRNewsWire • 07/28/21
Heron Therapeutics' Zynrelef Shows Reduction In Post-Op Pain, Opioid Use Compared To Bupivacaine In Old-Aged PatientsBenzinga • 07/22/21
Heron Therapeutics Announces Publication Showing Reduction of Pain and Opioid Use Compared to Bupivacaine in Patients 65 and Older with ZYNRELEF™PRNewsWire • 07/21/21
Heron Therapeutics Announces 340B Prime Vendor Contract with Apexus for ZYNRELEF™PRNewsWire • 07/06/21
Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF™ for the Management of Postoperative Pain for up to 72 HoursPRNewsWire • 07/01/21
Under Biden's Budget, These 2 Little-Known Biotechs Could Help End the Opioid CrisisThe Motley Fool • 06/02/21
Heron's Non-Opioid, Post-Operative Pain Drug Approved By FDA: Why This Is ImportantBenzinga • 05/13/21
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 HoursPRNewsWire • 05/13/21
Heron Stock Trading Higher After Q1 Earnings, Ahead Of HTX-011 Decision Scheduled This WeekBenzinga • 05/10/21
Heron Therapeutics (HRTX) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/10/21
Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Recent Corporate UpdatesPRNewsWire • 05/10/21
Will Heron Therapeutics (HRTX) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 04/28/21
Do Options Traders Know Something About Heron Therapeutics (HRTX) Stock We Don't?Zacks Investment Research • 04/07/21
Analysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 02/22/21
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development ProgramPRNewsWire • 01/11/21